What Type of Cancer Causes Low Hemoglobin?

The Link Between Cancer and Hemoglobin Levels

Cancer disrupts hemoglobin levels through several mechanisms. Tumor growth may cause internal bleeding, bone marrow suppression, or nutritional deficiencies. Additionally, chemotherapy and radiotherapy often impair red blood cell production, further compounding anemia. Evidence shows that hemoglobin decline can precede diagnosis in some cancers, making it an early signal of malignant disease.

Cancers Frequently Associated with Low Hemoglobin

Research indicates that not all cancers affect hemoglobin levels equally. Certain malignancies are strongly correlated with anemia due to their biological and clinical characteristics.

• Blood-Related Cancers: Hematologic malignancies such as leukemias and lymphomas are among the most closely linked to declining hemoglobin levels. Because these cancers originate in bone marrow or lymphatic tissues, they directly interfere with the body’s ability to produce red blood cells. Studies show significant hemoglobin decline before diagnosis in lymphatic leukemia and Hodgkin lymphoma.
• Gastrointestinal Cancers: Stomach and colon cancers frequently cause anemia, largely due to chronic bleeding in the digestive tract. Declines in hemoglobin can begin years before diagnosis, making anemia one of the earliest clinical clues for these malignancies.
• Ovarian Cancer: Ovarian cancer patients often develop anemia both before and during chemotherapy. Hemoglobin levels below 12 g/dL are strongly associated with reduced overall survival, highlighting anemia as a prognostic factor in ovarian cancer outcomes.
• Lung Cancer: Low hemoglobin levels are common in lung cancer and serve as an independent predictor of poor survival. More than half of lung cancer patients present with anemia at diagnosis, and survival rates are significantly reduced in those with low hemoglobin.
• Breast Cancer: Breast cancer is also linked with anemia, particularly due to treatment-related effects. Hypoxia within the tumor microenvironment contributes to declining hemoglobin levels, and low hemoglobin has been associated with poorer prognosis and reduced treatment efficacy.
• Cervical and Head & Neck Cancers: In cervical cancer, low hemoglobin levels independently predict worse treatment outcomes with radiotherapy and chemotherapy. Similarly, patients with head and neck cancers who develop anemia during treatment have significantly lower survival rates, especially when combined with prolonged treatment times.
• Melanoma and Prostate Cancer: Cutaneous malignant melanoma has been linked to low hemoglobin, particularly in patients with nodal involvement and metastatic disease, though anemia is not always an independent prognostic factor. Prostate cancer patients undergoing radiotherapy also experience significant drops in hemoglobin, emphasizing the need for monitoring during treatment.

Why Anemia Matters in Cancer

Low hemoglobin in cancer patients is not merely a side effect. It plays a critical role in patient survival and treatment outcomes. Anemia reduces oxygen delivery to tissues, creating tumor hypoxia, which diminishes the effectiveness of radiation and chemotherapy. Clinical studies consistently show that correcting anemia, when possible, improves both quality of life and survival prospects.

The Role of Hemoglobin in Cancer Care

Low hemoglobin is a hallmark of many cancers, particularly those of the blood, gastrointestinal system, ovaries, lungs, breast, cervix, and head and neck. It often signals disease severity, influences treatment outcomes, and worsens survival if left unaddressed. Monitoring and managing anemia in cancer care is therefore essential, not only to improve comfort and quality of life but also to enhance treatment success and survival.

Since low hemoglobin can be an early sign of cancer or other health conditions, getting tested is a proactive way to protect your health: